The severity of lung cancer in the Commonwealth

C. Hopenhayn,Todd Jenkins,Joe Petrik,A. M

Abstract:

What problem does this paper attempt to address?

Expertenempfehlung zur Magnetresonanztomographie bei Muskelerkrankungen

Rachel Zeng,Sarah Schlaeger,Matthias Türk,Thomas Baum,Marcus Deschauer,Rolf Janka,Dimitrios Karampinos,Jan Kassubek,Sarah Keller-Yamamura,Cornelia Kornblum,Helmar Lehmann,Thorsten Lichtenstein,Armin M. Nagel,Jens Reimann,Angela Rosenbohm,Lara Schlaffke,Manuel Schmidt,Christiane Schneider-Gold,Benedikt Schoser,Regina Trollmann,Matthias Vorgerd,Marc-André Weber,Jan S. Kirschke,Jens Schmidt

DOI: https://doi.org/10.1007/s00115-024-01673-x

2024-04-30

Der Nervenarzt

Abstract:Die Magnetresonanztomographie (MRT) der Skelettmuskulatur (kurz: Muskel-MRT) wird zunehmend routinemäßig zur Diagnose und Verlaufsbeurteilung von Muskelerkrankungen eingesetzt. Jedoch existierten bislang keine zentrumsübergreifenden Standards für Messprotokolle und die radiologische Befundung.

psychiatry,clinical neurology
Pre- and post-skeletal muscle biopsy quantitative magnetic resonance imaging reveals correlations with histopathological findings

Anne-Katrin Güttsches,Johannes Forsting,Moritz Kneifel,Robert Rehmann,Alice De Lorenzo,Elena Enax-Krumova,Martijn Froeling,Matthias Vorgerd,Lara Schlaffke

DOI: https://doi.org/10.1111/ene.16479

Abstract:Background and purpose: Quantitative muscle magnetic resonance imaging (MRI) is a promising non-invasive method in the diagnostic workup as well as follow-up of neuromuscular disorders. The aim of this study was to correlate quantitative MRI (qMRI) parameters to histopathological changes in skeletal muscle tissue and thus to verify the data from our pilot study. Methods: Twenty-six patients (eight females, 46.4 ± 15.1 years) were examined within 72 h before and within 24 h after a skeletal muscle biopsy using quantitative muscle MRI. Post-biopsy MRI was employed to pinpoint the exact localization of the biopsy. qMRI parameters including fat fraction, water T2 relaxation time and diffusion metrics including fractional anisotropy, mean diffusivity, axial diffusivity and radial diffusivity were extracted from the localization of the biopsy and correlated with histopathological findings. Additionally, three different segmentation masks were applied to the qMRI dataset, to evaluate whether the whole muscle represents the exact biopsy location. Results: Fat fraction and water T2 relaxation time in qMRI correlated significantly with the fat fraction in the muscle biopsy and histopathological inflammatory markers. Fractional anisotropy correlated with the quantity of type 2 fibres, whilst mean diffusivity correlated with p62. No differences were found using different segmentation masks in qMRI. Conclusions: In this follow-up study, the results from our previous study were verified regarding the correlation of qMRI parameters with histopathological features in muscle biopsies, indicating that qMRI serves as a suitable non-invasive method in the follow-up of patients with neuromuscular disorders. If post-biopsy MRI is not available, whole muscle volume can be used for histopathological correlations.
Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature

Nikolay Tzaribachev,C. Well,J. Schedel,M. Horger

DOI: https://doi.org/10.1007/s00296-009-0890-y

2009-03-20

Rheumatology International

Abstract:Juvenile Dermatomyositis (JDM) is a rare autoimmune disease in childhood. Distinction between muscle inflammation and a residual state can be difficult especially under immunosuppressive therapy and in active disease without correlating muscle enzyme tests or functional muscle scores. Our goal is to demonstrate the benefit of whole-body magnetic resonance imaging (MRI) as a diagnostic modality in the detection and management of JDM. One patient with JDM was monitored using clinical examination, muscle enzyme tests, muscle scores and whole-body MRI. During immunosuppression, the patient presented several times to our department without clear correlation between clinical picture, muscle enzyme tests and muscle scores. Whole-body MRI proved reliable in assessing the true state of the disease, thus providing invaluable information in the management of the inflammatory myopathy. This is of utmost importance for the therapeutic optimization in order to prevent further damage especially in children with active but subclinical disease.

rheumatology
Evaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI

Lara Schlaffke,Robert Rehmann,Anne-Katrin Güttsches,Matthias Vorgerd,Christine H. Meyer-Frießem,Hubert R. Dinse,Elena Enax-Krumova,Martijn Froeling,Johannes Forsting

DOI: https://doi.org/10.3390/jcm13071958

IF: 3.9

2024-03-29

Journal of Clinical Medicine

Abstract:Background: Quantitative muscle MRI (qMRI) is a promising tool for evaluating and monitoring neuromuscular disorders (NMD). However, the application of different imaging protocols and processing pipelines restricts comparison between patient cohorts and disorders. In this qMRI study, we aim to compare dystrophic (limb-girdle muscular dystrophy), inflammatory (inclusion body myositis), and metabolic myopathy (Pompe disease) as well as patients with post-COVID-19 conditions suffering from myalgia to healthy controls. Methods: Ten subjects of each group underwent a 3T lower extremity muscle MRI, including a multi-echo, gradient-echo, Dixon-based sequence, a multi-echo, spin-echo (MESE) T2 mapping sequence, and a spin-echo EPI diffusion-weighted sequence. Furthermore, the following clinical assessments were performed: Quick Motor Function Measure, patient questionnaires for daily life activities, and 6-min walking distance. Results: Different involvement patterns of conspicuous qMRI parameters for different NMDs were observed. qMRI metrics correlated significantly with clinical assessments. Conclusions: qMRI metrics are suitable for evaluating patients with NMD since they show differences in muscular involvement in different NMDs and correlate with clinical assessments. Still, standardisation of acquisition and processing is needed for broad clinical use.

medicine, general & internal
Novel Muscle Imaging in Inflammatory Rheumatic Diseases-A Focus on Ultrasound Shear Wave Elastography and Quantitative MRI

Matthew Farrow,John Biglands,Abdulrahman M Alfuraih,Richard J Wakefield,Ai Lyn Tan

DOI: https://doi.org/10.3389/fmed.2020.00434

2020-08-12

Abstract:In recent years, imaging has played an increasing role in the clinical management of patients with rheumatic diseases with respect to aiding diagnosis, guiding therapy and monitoring disease progression. These roles have been underpinned by research which has enhanced our understanding of disease pathogenesis and pathophysiology of rheumatology conditions, in addition to their key role in outcome measurement in clinical trials. However, compared to joints, imaging research of muscles is less established, despite the fact that muscle symptoms are very common and debilitating in many rheumatic diseases. Recently, it has been shown that even though patients with rheumatoid arthritis may achieve clinical remission, defined by asymptomatic joints, many remain affected by lingering constitutional systemic symptoms like fatigue, tiredness, weakness and myalgia, which may be attributed to changes in the muscles. Recent improvements in imaging technology, coupled with an increasing clinical interest, has started to ignite new interest in the area. This perspective discusses the rationale for using imaging, particularly ultrasound and MRI, for investigating muscle pathology involved in common inflammatory rheumatic diseases. The muscles associated with rheumatic diseases can be affected in many ways, including myositis-an inflammatory muscle condition, and myopathy secondary to medications, such as glucocorticoids. In addition to non-invasive visual assessment of muscles in these conditions, novel imaging techniques like shear wave elastography and quantitative MRI can provide further useful information regarding the physiological and biomechanical status of the muscle.
Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum

Lea-Katharina Zierer,Steffen Naegel,Ilka Schneider,Thomas Kendzierski,Kathleen Kleeberg,Anna Katharina Koelsch,Leila Scholle,Christoph Schaefer,Arne Naegel,Stephan Zierz,Markus Otto,Gisela Stoltenburg-Didinger,Torsten Kraya,Dietrich Stoevesandt,Alexander Mensch

DOI: https://doi.org/10.1007/s00415-024-12191-w

2024-03-06

Journal of Neurology

Abstract:Objective Inflammatory myopathies (IIM) include dermatomyositis (DM), sporadic inclusion body myositis (sIBM), immune-mediated necrotizing myopathy (IMNM), and overlap myositis (OLM)/antisynthetase syndrome (ASyS). There is also a rare variant termed polymyositis with mitochondrial pathology (PM-Mito), which is considered a sIBM precursor. There is no information regarding muscle MRI for this rare entity. The aim of this study was to compare MRI findings in IIM, including PM-Mito. Methods This retrospective analysis included 41 patients (7 PM-Mito, 11 sIBM, 11 PM/ASyS/OLM, 12 IMNM) and 20 healthy controls. Pattern of muscle involvement was assessed by semiquantitative evaluation, while Dixon method was used to quantify muscular fat fraction. Results The sIBM typical pattern affecting the lower extremities was not found in the majority of PM-Mito-patients. Intramuscular edema in sIBM and PM-Mito was limited to the lower extremities, whereas IMNM and PM/ASyS/OLM showed additional edema in the trunk. Quantitative assessment showed increased fat content in sIBM, with an intramuscular proximo-distal gradient. Similar changes were also found in a few PM-Mito- and PM/ASyS/OLM patients. In sIBM and PM-Mito, mean fat fraction of several muscles correlated with clinical involvement. Interpretation As MRI findings in patients with PM-Mito relevantly differed from sIBM, the attribution of PM-Mito as sIBM precursor should be critically discussed. Some patients in PM/ASyS/OLM and PM-Mito group showed MR-morphologic features predominantly observed in sIBM, indicative of a spectrum from PM/ASyS/OLM toward sIBM. In some IIM subtypes, MRI may serve as a biomarker of disease severity.

clinical neurology
ANALYSIS OF KINASE INHIBITOR ACTION IN LEUKEMIA TREATMENTS

H. Schneider,M. Kaiser,L. Mursina

Abstract:In clinical metabolomics biomarker discovery is conducted by the complementary power of clinical study design and execution, molecular profiling technologies and an efficient bioinformatics strategy for biomarker search, verification and interpretation. This survey article gives a review of useful bioinformatics methods for biomarker discovery, addressing the problem of data preprocessing, the data-driven search, prioritization and biological interpretation of metabolic biomarkers candidates in disase. Advanced data mining approaches and new strategies using networkbased methods are discussed in more detail. Keywords: Biomarker discovery, metabolomics, bioinformatics, complex disease  
Magnetic resonance imaging of the musculoskeletal system in the diagnosis of rheumatic diseases in the pediatric population

Joanna Karolina Ożga,Elżbieta Mężyk,Wojciech Kmiecik,Wadim Wojciechowski,Zbigniew Żuber

DOI: https://doi.org/10.5114/reum/190262

2024-07-12

Rheumatology

Abstract:Magnetic resonance imaging (MRI) of the musculoskeletal system is an examination increasingly performed for suspected juvenile idiopathic arthritis, chronic nonbacterial osteomyelitis and juvenile idiopathic inflammatory myopathies, as well as other rheumatic diseases of developmental age. T1-, T2- and PD-weighted with or without fat suppression or short tau inversion recovery/turbo inversion recovery magnitude (STIR/TIRM) sequences and post-contrast sequences are evaluated to diagnose pathological changes in the synovial membrane, subchondral bone marrow and surrounding soft tissues. Magnetic resonance imaging allows detection of synovitis, tenosynovitis, bursitis, and enthesitis as well as bone marrow edema and soft tissue edema. Several pediatric-specific MRI scoring systems have been developed and validated to standardize and facilitate the assessment of the extent of the inflammatory process and disease activity in MRI. Early detection of inflammatory changes allows the inclusion of comprehensive pharmacotherapy giving the possibility of permanent remission and objective measurement of the effectiveness of treatment.

rheumatology
Current approach to muscle imaging in myositis

Didem Saygin,Jemima Albayda

DOI: https://doi.org/10.1097/BOR.0000000000001043

2024-08-23

Abstract:Purpose of review: Muscle imaging is commonly utilized in idiopathic inflammatory myopathies (IIM) for diagnostic evaluation, selection of muscle biopsy site, and differentiating between disease activity versus damage. In this review, we discuss the current state and recent developments in the use of muscle imaging modalities including muscle magnetic resonance imaging (MRI), ultrasound (US), and positron emission tomography (PET) scan. Recent findings: Muscle MRI is a clinically useful tool in evaluation of IIM with studies showing good correlations between pattern of morphological changes on MRI and histopathological findings on muscle biopsy. The use of computer aided diagnostics to enable quantification of muscle pathology will be a welcome development for future studies and trials. New studies highlight that muscle US could be a particularly useful point of care tool in longitudinal monitoring of patients with active myositis. Muscle FDG-PET scan shows inflammatory activity in IIM muscle and can also provide additional information on extra-muscular manifestations and cancer screening. Utilization of novel tracers is an exciting development for IIM evaluation. Summary: Muscle MRI remains the gold standard for muscle imaging in IIM. Growing literature on muscle US and PET scan highlight their promising applications in IIM.
Dynamic MR of muscle contraction during electrical muscle stimulation as a potential diagnostic tool for neuromuscular disease

Francesco Santini,Michele Giovanni Croce,Xeni Deligianni,Matteo Paoletti,Leonardo Barzaghi,Niels Bergsland,Arianna Faggioli,Giulia Manco,Chiara Bonizzoni,Ning Jin,Sabrina Ravaglia,Anna Pichiecchio

DOI: https://doi.org/10.1101/2024.09.17.24313673

2024-09-18

Abstract:Thanks to the rapid evolution of therapeutic strategies for muscular and neuromuscular diseases, the identification of quantitative biomarkers for disease identification and monitoring has become crucial. Magnetic resonance imaging (MRI) has been playing an important role by noninvasively assessing structural and functional muscular changes. This exploratory study investigated the potential of dynamic MRI during neuromuscular electrical stimulation (NMES) to detect differences between healthy controls (HCs) and patients with metabolic and myotonic myopathies. The study included 14 HCs and 10 patients with confirmed muscular diseases. All individuals were scanned with 3T MRI with a protocol that included a multi-echo gradient echo sequence for fat fraction quantification, multi-echo spin-echo for water T2 relaxation time calculation, and 3D phase contrast sequences during NMES. The strain tensor, buildup and release rates were calculated from velocity datasets. Results showed that strain and strain buildup rate were reduced in the soleus muscle of patients compared to HCs, suggesting these parameters could serve as biomarkers of muscle dysfunction. Notably, there were no significant differences in fat fraction or water T2 measurements between patients and HCs, indicating that the observed changes reflect alterations in muscle contractile properties that are not reflected by structural changes. The findings provide preliminary evidence that dynamic muscle MRI during NMES can detect abnormalities in muscle contraction in patients with myotonia and metabolic myopathies, warranting further research with larger, more homogeneous patient cohorts.

Radiology and Imaging
D.C. General Hospital: the nurse specialist hypertension clinic.

J. R. Mcpherson,W. Mroczek

1979-03-01

Abstract:
Magnetic resonance imaging of muscle injury

Dong YAN,Jing-xiu ZHANG,Jing ZHANG,Wei LIU,Hui QU,Xiao-guang CHENG

DOI: https://doi.org/10.3321/j.issn:1003-3289.2008.06.004

2008-01-01

Abstract:Objective To define the MR imaging features of muscle injury.Methods MRI exams of 15 patients with clinical suspicion for muscle injury were reviewed and 7 patients had been followed up.MRI findings of these patients were evaluated by two senior musculoskeletal radiologists retrospectively.Results Thirteen patients(87%)had low-extremity involvement in 15 cases.Five cases were muscle strain and intermediate signal intensity was showed on T1WI and high signal region of the linear or lobed was noted on T2WI and STIR or frFSE FS in injured muscle.Ten cases were intramuscular hematomas and all patients demonstrated the high signal intensity on T2WI and STIR or frFSE FS.But there were different signal intensity on T1WI and 3 cases showed low signal and 3 cases had intermediate signal and the rests showed the confusing slightly high or high signal.Conclusion MRI is one of the best choices for imaging muscle injuries.
Volumetric muscle composition analysis in sporadic inclusion body myositis using fat‐referenced magnetic resonance imaging: Disease pattern, repeatability, and natural progression

John Heerfordt,Markus Karlsson,Midori Kusama,Seiya Ogata,Ryuta Mukasa,Naoki Kiyosawa,Noriko Sato,Per Widholm,Olof Dahlqvist Leinhard,André Ahlgren,Madoka Mori‐Yoshimura

DOI: https://doi.org/10.1002/mus.28252

2024-09-26

Muscle & Nerve

Abstract:Introduction/Aims Fat‐referenced magnetic resonance imaging (MRI) has emerged as a promising volumetric technique for measuring muscular volume and fat in neuromuscular disorders, but the experience in inflammatory myopathies remains limited. Therefore, this work aimed at describing how sporadic inclusion body myositis (sIBM) manifests on standardized volumetric fat‐referenced MRI muscle measurements, including within‐scanner repeatability, natural progression rate, and relationship to clinical parameters. Methods Ten sIBM patients underwent whole‐leg Dixon MRI at baseline (test–retest) and after 12 months. The lean muscle volume (LMV), muscle fat fraction (MFF), and muscle fat infiltration (MFI) of the quadriceps, hamstrings, adductors, medial gastrocnemius, and tibialis anterior were computed. Clinical assessments of IBM Functional Rating Scale (IBMFRS) and knee extension strength were also performed. The baseline test–retest MRI measurements were used to estimate the within‐subject standard deviation (sw). 12‐month changes were derived for all parameters. Results The MRI measurements showed high repeatability in all muscles; sw ranged from 2.7 to 18.0 mL for LMV, 0.7–1.3 percentage points (pp) for MFF, and 0.2–0.7 pp for MFI. Over 12 months, average LMV decreased by 7.4% while MFF and MFI increased by 3.8 pp and 1.8 pp, respectively. Mean IBMFRS decreased by 2.4 and mean knee extension strength decreased by 32.8 N. Discussion The MRI measurements showed high repeatability and 12‐month changes consistent with muscle atrophy and fat replacement as well as a decrease in both muscle strength and IBMFRS. Our findings suggest that fat‐referenced MRI measurements are suitable for assessing disease progression and treatment response in inflammatory myopathies.

neurosciences,clinical neurology
Research of utilizing MRI to diagnose and evaluate the effect of inflammatory myopathies

ZHANG Shou-cheng,LU Jian-xin,SUN Ling-yun,ZHOU Xiao-qing

DOI: https://doi.org/10.3969/j.issn.1005-8982.2010.24.031

2010-01-01

Abstract:【Objective】To evaluate the utility of the magnetic resonance imaging(MRI) in diagnosis of inflammatory myopathies,so as to explore whether it can be used as a tool for curative efficacy evaluation.【Methods】30 patients with inflammatory myopathies and 12 patients with muscle soreness were scanned with MRI upon their thighs,the results of MRI were compared.The sensitivity of MRI,CPK and muscle biopsy for diagnosing inflammatory myopathies was compared.【Results】30 patients with inflammatory myopathies and 12 patients with muscle soreness were scanned with MRI upon their thighs.28 patients with inflammatory myopathies had abnomal MRI signals except 2 patients had normal manifestations.12 controls had normal manifestations on MRI.All of 4 patients with acute onset of test group had abnormal signals.The anterior group of thigh muscle with abnormal signal accounted for 93.33%(28 cases of 30),the posterior group of thigh muscle with abnormal signal accounted for 76.67%(23 cases of 30),the medial group accounted for16.67%(5 cases of 30).The sensitivity of MRI for diagnosing myositis was no higher than that of the CPK and the muscle biopsy(P 0.05).Rechecked MRI showed the original lesions got smaller or vanished.【Conclusions】MRI may be an alternative effective method for the diagnosis of inflammatory myopathies,combining of Fast-echo sequences and Fat-suppressed fast turnover sequences can make the diagnosis more accurately.MRI can be regarded as one of the tools for evaluating the curative effect.Besides,it can be helpful to find the smaller lesions of muscles and lead to the accurate biopsy.
Magnetic Resonance Imaging Patterns Revealing Muscle Pathology and Clinical Features in Idiopathic Inflammatory Myopathies

Takashi Shimoyama,Ken Yoshida,Yoshinao Muro,Haruyasu Ito,Takayuki Matsushita,Yohsuke Oto,Taro Ukichi,Kentaro Noda,Daitaro Kurosaka

DOI: https://doi.org/10.1093/rheumatology/keae125

2024-02-26

Rheumatology

Abstract:Abstract Objective Idiopathic inflammatory myopathies (IIMs) are autoimmune disorders significantly impacting skeletal muscles; however, the precise correlation between muscle magnetic resonance imaging (MRI) findings, muscle pathology, disease subtypes, and clinical characteristics remains uncertain. Thus, we investigated the association of muscle MRI findings in IIMs with muscle pathology and clinical features. Methods New-onset IIM patients underwent proximal upper and/or lower limb muscle MRI. Patterns of muscle oedema on MRI were categorised into fascial, honeycomb, peripheral, foggy, dense, or coarse dot patterns and compared with inflammatory cell infiltration sites in corresponding muscle biopsies. The incidence of MRI patterns was examined in patient subgroups using myositis-specific antibodies (MSAs) and 2017 EULAR/ACR classification criteria. Univariate and multivariate analyses were conducted to determine the odds ratios (ORs) of MRI findings for clinical characteristics. Results Fifty-six of 85 patients underwent muscle biopsy. Foggy, honeycomb, and fascial patterns at biopsy sites correlated with inflammatory cell infiltration in the endomysium (OR 11.9, p= 0.005), perimysium (OR 6.0, p= 0.014), and fascia (OR 16.9, p< 0.001), respectively. Honeycomb and foggy patterns were characteristic of patients with anti-TIF1γ or anti-Mi2 antibodies and MSA-negative dermatomyositis, and those with anti-SRP or anti-HMGCR antibodies and MSA-negative polymyositis (PM), respectively. The honeycomb pattern positively correlated with malignancy (OR 6.87, p< 0.001) and Gottron sign (OR 8.05, p= 0.002); the foggy pattern correlated with muscle weakness (OR 11.24, p= 0.005). The dense dot pattern was associated with dysphagia (OR 6.27, p= 0.006) and malignancy (OR 8.49, p= 0.002). Conclusion Muscle MRI holds promise in predicting muscle pathology, disease subtypes, and clinical manifestations of IIMs.

rheumatology
Motor Unit Magnetic Resonance Imaging (MUMRI) In Skeletal Muscle

Linda Heskamp,Matthew G. Birkbeck,Daniel Baxter‐Beard,Julie Hall,Ian. S. Schofield,Mathew Elameer,Roger G. Whittaker,Andrew M. Blamire

DOI: https://doi.org/10.1002/jmri.29218

IF: 4.4

2024-01-13

Journal of Magnetic Resonance Imaging

Abstract:Magnetic resonance imaging (MRI) is routinely used in the musculoskeletal system to measure skeletal muscle structure and pathology in health and disease. Recently, it has been shown that MRI also has promise for detecting the functional changes, which occur in muscles, commonly associated with a range of neuromuscular disorders. This review focuses on novel adaptations of MRI, which can detect the activity of the functional sub‐units of skeletal muscle, the motor units, referred to as "motor unit MRI (MUMRI)." MUMRI utilizes pulsed gradient spin echo, pulsed gradient stimulated echo and phase contrast MRI sequences and has, so far, been used to investigate spontaneous motor unit activity (fasciculation) and used in combination with electrical nerve stimulation to study motor unit morphology and muscle twitch dynamics. Through detection of disease driven changes in motor unit activity, MUMRI shows promise as a tool to aid in both earlier diagnosis of neuromuscular disorders and to help in furthering our understanding of the underlying mechanisms, which proceed gross structural and anatomical changes within diseased muscle. Here, we summarize evidence for the use of MUMRI in neuromuscular disorders and discuss what future research is required to translate MUMRI toward clinical practice. Level of Evidence 5 Technical Efficacy Stage 3

radiology, nuclear medicine & medical imaging
Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of LMNA -Related Muscular Dystrophy.

Hui-Ting Lin,Xiao Liu,Wei Zhang,Jing Liu,Yue-Huan Zuo,Jiang-Xi Xiao,Ying Zhu,Yun Yuan,Zhao-Xia Wang

DOI: https://doi.org/10.4103/0366-6999.233957

IF: 6.133

2018-01-01

Chinese Medical Journal

Abstract:Background: LMNA-related muscular dystrophy can manifest in a wide variety of disorders, including Emery-Dreifuss muscular dystrophy (EDMD), limb-girdle muscular dystrophy (LGMD), and LMNA-associated congenital muscular dystrophy (L-CMD). Muscle magnetic resonance imaging (MRI) has become a useful tool in the diagnostic workup of patients with muscle dystrophies. This study aimed to investigate whether there is a consistent pattern of MRI changes in patients with LMNA mutations in various muscle subtypes. Methods: Twenty-two patients with LMNA-related muscular dystrophies were enrolled in this study. MRI of the thigh and/or calf muscles was performed in them. The muscle MRI features of the three subtypes were compared by the Mann-Whitney U-test. The relationship between the clinical and MRI findings was also investigated by Spearman's rank analyses. Results: The present study included five EDMD, nine LGMD, and eight L-CMD patients. The thigh muscle MRI revealed that the fatty infiltration of the adductor magnus, semimembranosus, long and short heads of the biceps femoris, and vasti muscles, with relative sparing of the rectus femoris, was the predominant change observed in the EDMD, LGMD, and advanced-stage L-CMD phenotypes, although the involvement of the vasti muscles was not prominent in the early stage of L-CMD. At the level of the calf, six patients (one EDMD, four LGMD, and one L-CMD) also showed a similar pattern, in which the soleus and the medial and lateral gastrocnemius muscles were most frequently observed to have fatty infiltration. The fatty infiltration severity demonstrated higher scores associated with disease progression, with a corresponding rate of 1.483 + 0.075 x disease duration (X) (r = 0.444, P = 0.026). It was noteworthy that in six L-CMD patients with massive inflammatory cell infiltration in muscle pathology, no remarkable edema-like signals were observed in muscle MRI. Conclusions: EDMD, LGMD and advanced-staged L-CMD subtypes showed similar pattern of muscle MRI changes, while early-staged L-CMD showed somewhat different changes. Muscle MRI of L-CMD with a muscular dystrophy pattern in MRI provided important clues for differentiating it from childhood inflammatory myopathy. The fatty infiltration score could be used as a reliable biomarker for outcome measure of disease progression.
Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI

Gustav J Strijkers,Ericky C A Araujo,Noura Azzabou,David Bendahan,Andrew Blamire,Jedrek Burakiewicz,Pierre G Carlier,Bruce Damon,Xeni Deligianni,Martijn Froeling,Arend Heerschap,Kieren G Hollingsworth,Melissa T Hooijmans,Dimitrios C Karampinos,George Loudos,Guillaume Madelin,Benjamin Marty,Armin M Nagel,Aart J Nederveen,Jules L Nelissen,Francesco Santini,Olivier Scheidegger,Fritz Schick,Christopher Sinclair,Ralph Sinkus,Paulo L de Sousa,Volker Straub,Glenn Walter,Hermien E Kan

DOI: https://doi.org/10.3233/JND-180333

Abstract:Neuromuscular diseases are characterized by progressive muscle degeneration and muscle weakness resulting in functional disabilities. While each of these diseases is individually rare, they are common as a group, and a large majority lacks effective treatment with fully market approved drugs. Magnetic resonance imaging and spectroscopy techniques (MRI and MRS) are showing increasing promise as an outcome measure in clinical trials for these diseases. In 2013, the European Union funded the COST (co-operation in science and technology) action BM1304 called MYO-MRI (www.myo-mri.eu), with the overall aim to advance novel MRI and MRS techniques for both diagnosis and quantitative monitoring of neuromuscular diseases through sharing of expertise and data, joint development of protocols, opportunities for young researchers and creation of an online atlas of muscle MRI and MRS. In this report, the topics that were discussed in the framework of working group 3, which had the objective to: Explore new contrasts, new targets and new imaging techniques for NMD are described. The report is written by the scientists who attended the meetings and presented their data. An overview is given on the different contrasts that MRI can generate and their application, clinical needs and desired readouts, and emerging methods.
Whole-body muscle magnetic resonance imaging in inflammatory myopathy with mitochondrial pathology

Wagner Cid Palmeira Cavalcante,André Macedo Serafim da Silva,Rodrigo de Holanda Mendonça,Cristiane de Araújo Martins Moreno,Bruna Moreira de Souza Proença,Júlio Brandão Guimarães,Alípio Gomes Ormond Filho,Edmar Zanoteli

DOI: https://doi.org/10.3389/fneur.2024.1386293

IF: 3.4

2024-04-24

Frontiers in Neurology

Abstract:Introduction: Inflammatory myopathy with mitochondrial pathology (IM-Mito) is a rare condition described in a few case series, and it is not clear whether it is a specific disease or a variant of Inclusion Body Myositis (IBM). Radiological data of IM-Mito patients has only been evaluated in one study. Aim: To analyze whole-body muscle magnetic resonance imaging (MRI) features in patients with IM-Mito compared with individuals with IBM. Methods: Fourteen IM-Mito and ten IBM patients were included. IM-Mito was defined by endomysial inflammatory infiltrate, presence of at least 1% of Cytochrome C Oxidase negative fibers, and absence of rimmed vacuoles in muscle biopsy; and IBM was defined by the presence of dystrophic muscular abnormalities, endomysial inflammatory infiltrate, and rimmed vacuoles. Patients underwent clinical evaluation and whole-body muscle MRI to determine the presence of edema, and fatty infiltration in various muscles. Results: Muscle imaging abnormalities were asymmetric in most patients with IM-Mito and IBM. Muscles with the highest average degree of fatty infiltration in both conditions were the quadriceps and medial gastrocnemius. Most patients with IM-Mito and IBM showed imaging patterns of rectus femoris relatively spared compared to other quadriceps muscles. The flexor digitorum profundus was the most affected muscle of the upper limbs in both IBM and IM-Mito. Discussion: Although the results suggest some similarities in muscle imaging features between IM-Mito and IBM, there remains uncertainty whether these two conditions are part of the same clinical spectrum.

neurosciences,clinical neurology
Magnetic resonance elastography in a nutshell: Tomographic imaging of soft tissue viscoelasticity for detecting and staging disease with a focus on inflammation

Tom Meyer,Johannes Castelein,Jakob Schattenfroh,Anna Sophie Morr,Rafaela Vieira da Silva,Heiko Tzschätzsch,Rolf Reiter,Jing Guo,Ingolf Sack

DOI: https://doi.org/10.1016/j.pnmrs.2024.05.002

IF: 9.447

2024-06-01

Progress in Nuclear Magnetic Resonance Spectroscopy

Abstract:Magnetic resonance elastography (MRE) is an emerging clinical imaging modality for characterizing the viscoelastic properties of soft biological tissues. MRE shows great promise in the noninvasive diagnosis of various diseases, especially those associated with soft tissue changes involving the extracellular matrix, cell density, or fluid turnover including altered blood perfusion – all hallmarks of inflammation from early events to cancer development. This review covers the fundamental principles of measuring tissue viscoelasticity by MRE, which are based on the stimulation and encoding of shear waves and their conversion into parameter maps of mechanical properties by inverse problem solutions of the wave equation. Technical challenges posed by real-world biological tissue properties such as viscosity, heterogeneity, anisotropy, and nonlinear elastic behavior of tissues are discussed. Applications of MRE measurement in both humans and animal models are presented, with emphasis on the detection, characterization, and staging of diseases related to the cascade of biomechanical property changes from early to chronic inflammation in the liver and brain. Overall, MRE provides valuable insights into the biophysics of soft tissues for imaging-based detection and staging of inflammation-associated tissue changes.

chemistry, physical,spectroscopy,physics, atomic, molecular & chemical

The severity of lung cancer in the Commonwealth

Expertenempfehlung zur Magnetresonanztomographie bei Muskelerkrankungen

Pre- and post-skeletal muscle biopsy quantitative magnetic resonance imaging reveals correlations with histopathological findings

Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature

Evaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI

Novel Muscle Imaging in Inflammatory Rheumatic Diseases-A Focus on Ultrasound Shear Wave Elastography and Quantitative MRI

Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum

ANALYSIS OF KINASE INHIBITOR ACTION IN LEUKEMIA TREATMENTS

Magnetic resonance imaging of the musculoskeletal system in the diagnosis of rheumatic diseases in the pediatric population

Current approach to muscle imaging in myositis

Dynamic MR of muscle contraction during electrical muscle stimulation as a potential diagnostic tool for neuromuscular disease

D.C. General Hospital: the nurse specialist hypertension clinic.

Magnetic resonance imaging of muscle injury

Volumetric muscle composition analysis in sporadic inclusion body myositis using fat‐referenced magnetic resonance imaging: Disease pattern, repeatability, and natural progression

Research of utilizing MRI to diagnose and evaluate the effect of inflammatory myopathies

Magnetic Resonance Imaging Patterns Revealing Muscle Pathology and Clinical Features in Idiopathic Inflammatory Myopathies

Motor Unit Magnetic Resonance Imaging (MUMRI) In Skeletal Muscle

Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of LMNA -Related Muscular Dystrophy.

Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI

Whole-body muscle magnetic resonance imaging in inflammatory myopathy with mitochondrial pathology

Magnetic resonance elastography in a nutshell: Tomographic imaging of soft tissue viscoelasticity for detecting and staging disease with a focus on inflammation